CRP levels potentially useful in chronic spontaneous urticaria

December 6, 2017

(HealthDay)—C-reactive protein (CRP) levels are frequently elevated in patients with chronic spontaneous urticaria (CSU), and these elevations are relevant and potentially useful in management of the condition, according to a study published online Nov. 12 in Allergy.

Pavel Kolkhir, M.D., Ph.D., from Charité - Universitätsmedizin Berlin, and colleagues retrospectively analyzed data from 1,253 CSU patients from two centers to determine the prevalence of elevated levels of CRP. Serum CRP was measured using the nephelometric method.

The researchers found that one-third of patients exhibiting CSU had elevated levels of CRP. Factors associated with higher levels of CRP included autologous serum skin test positivity (P = 0.009) and (P = 0.005). CRP correlated with urticaria activity (P < 0.001) and quality-of-life impairment (P = 0.026), as well as inflammatory and coagulation markers (P < 0.001). Compared to patients who did responded to antihistamines, CRP levels were significantly higher in non-responders (P < 0.001).

"The assessment of CRP levels may help to optimize the management of patients with CSU," the authors write.

Explore further: Considerable humanistic impact for chronic spontaneous urticaria

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Considerable humanistic impact for chronic spontaneous urticaria

May 31, 2017
(HealthDay)—Chronic spontaneous urticaria (CSU) interferes with sleep and daily activity, impairing work productivity, and patients frequently report angioedema, according to a study published online May 19 in Allergy.

Soluble interleukin 2 receptor IDs sarcoidosis in uveitis

November 13, 2017
(HealthDay)—Soluble interleukin 2 receptor (sIL-2R) has slightly better diagnostic value than angiotensin-converting enzyme (ACE) for sarcoidosis in patients with uveitis, according to a study published online Nov. 9 in ...

Doxycycline helps one-third of chronic cold urticaria patients

July 11, 2016
(HealthDay)—Just over one-third of chronic cold urticaria patients benefit from treatment with doxycycline, according to a research letter published online June 25 in the British Journal of Dermatology.

Memantine linked to lower neuron-specific enolase in TBI

July 27, 2017
(HealthDay)—For patients with moderate traumatic brain injury (TBI), memantine is associated with reduced neuronal damage, as assessed by serum levels of neuron-specific enolase (NSE), according to a study published online ...

uPAR elevated in bronchial tissue of asthma patients

September 23, 2016
(HealthDay)—Urokinase plasminogen activator receptor (uPAR) is elevated in patients with asthma, with high uPAR levels linked to severe, non-atopic disease, according to a study published online Sept. 14 in Allergy.

Serum cystatin C predicts mortality with cirrhotic ascites

September 23, 2017
(HealthDay)—Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites, according to a study published online Sept. 14 in the Journal of Gastroenterology and Hepatology.

Recommended for you

Immune cells turn back time to achieve memory

December 13, 2017
Memory T cells earn their name by embodying the memory of the immune system - they help the body remember what infections or vaccines someone has been exposed to. But to become memory T cells, the cells go backwards in time, ...

Steroid study sheds light on long term side effects of medicines

December 13, 2017
Fresh insights into key hormones found in commonly prescribed medicines have been discovered, providing further understanding of the medicines' side effects.

The immune cells that help tumors instead of destroying them

December 12, 2017
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

Researchers bring new insight into Chediak-Higashi syndrome, a devastating genetic disease

December 12, 2017
A team of researchers from the National Institutes of Health and University of Manchester have uncovered new insights into a rare genetic disease, with less than 500 cases of the disease on record, which devastates the lives ...

Drug increases speed, safety of treatment for multiple food allergies

December 11, 2017
In a randomized, controlled phase-2 clinical trial, an asthma medication increased the speed and safety of a protocol used to treat children for several food allergies at once, according to a study by researchers at the Stanford ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.